PRTK News and Press, Paratek Pharmaceuticals Inc. From 08/05/20

BOSTON, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, go...

BOSTON, July 28, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, go...

BOSTON, May 29, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, gove...

BOSTON, May 28, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, gove...

Doing business without advertising is like winking at a girl in the dark. You know what you are doing but nobody else does ." - Steuart Henderson Britt Today, we take a look at my favorite antibiotic concern in the market and the only one I own within my personal portfolio. The company po...

BOSTON, May 11, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, gove...

The following slide deck was published by Paratek Pharmaceuticals, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Paratek Pharmaceuticals, Inc. (PRTK) Q1 2020 Earnings Conference Call May 11, 2020 8:30 AM ET Company Participants Ben Strain - Vice President, Investor Relations and Corporate Communications Evan Loh - Chief Executive Officer Adam Woodrow - President and Chief Commercial Offic...

            -- Announced Initiation of Funding from BARDA for All FDA Required Post-Marketing Studies and Security Requirements and U.S. Onshoring of an Additional Manufacturing Supply Chain for NUZYRA BOSTON, May 11, 2020 (GLOBE NEWSWIRE) -- Paratek P...

Coronavirus Pandemic Junshi Biosciences [HK:1877] out-licensed ex-China rights for a therapeutic antibody aimed at preventing and treating COVID-19 to Eli Lilly (LLY) (see story ). JS016 is a recombinant fully human monoclonal neutralizing antibody that is specific to the SARS-CoV-2 surface...